|
Multimedia
Images, audio, and video related to cancer research
Calendar
Meetings, seminars, and press conferences focused on cancer research
Resources
Information on cancer types, treatment, prevention, and more
 Sponsored by:
The Cancer News Portal is supported by the National Cancer Institute of the National Institutes of Health. Additional information on cancer research, prevention, and treatment is available at www.cancer.gov |
Breaking News
Key: Meeting
Showing releases 76-100 out of 1216. << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>
Public Release: 22-Jul-2013
 Nature Scientific ReportsHealth risks from arsenic in rice exposed High levels of arsenic in rice have been shown to be associated with elevated genetic damage in humans, a new study has found. 
UK-India Education Research Initiative, British Council, Indian Institute of Chemical Biology Network Project
Contact: Aeron Haworth
Public Release: 22-Jul-2013
Pediatric Blood & CancerStudy highlights female cancer patients unhappy with insufficient fertility support Young female cancer patients are unhappy about the way fertility preservation options are discussed with them by doctors before starting cancer treatment, according to a new study by researchers from the University of Sheffield and The Children's Hospital, Sheffield. Contact: Amy Pullan
Public Release: 22-Jul-2013
Molecular Cancer TherapeuticsNew hope for hormone resistant breast cancer A new finding provides fresh hope for the millions of women worldwide with oestrogen receptor positive breast cancer. Australian scientists have shown that a specific change, which occurs when tumours become resistant to anti-oestrogen therapy, might make the cancers susceptible to treatment with chemotherapy drugs. Contact: Alison Heather
Public Release: 22-Jul-2013
ImmunityPutting the brakes on inflammation A team led by a UA researcher has discovered a previously unknown mechanism that prevents the immune system from going into overdrive. The findings shed light on the mechanisms underlying autoimmune disorders such as Crohn's disease, allergies, chronic inflammation and cancer, and offer potential applications for therapies. Contact: Daniel Stolte
Public Release: 22-Jul-2013
Journal of Clinical InvestigationProtein complex linked to cancer growth may also help fight tumors, Moffitt researchers say Researchers at Moffitt Cancer Center and Tianjin Medical University Cancer Institute and Hospital in China have discovered a gene expression signature that may lead to new immune therapies for lung cancer patients. They found that NF-κB, a protein complex known to promote tumor growth, may also have the ability to boost the immune system to eliminate cancerous cells before they harm, as well as promote antitumor responses.
NIH/National Cancer Institute
Contact: Kim Polacek
Public Release: 22-Jul-2013
82 percent of adults support banning smoking when kids are in the car A new poll shows 82 percent of adults support banning smoking in cars when children under 13 are riding in the vehicle. Contact: Mary Masson
Public Release: 22-Jul-2013
American Journal of Public HealthUniversity of Hawaii Cancer Center researchers report University of Hawaii Cancer Center Prevention and Control Program researchers Pallav Pokhrel, Ph.D., and Thaddeus Herzog, Ph.D., have found that smokers who use e-cigarettes as a tool to stop smoking tend to be younger and more motivated to quit smoking as compared to other smokers. Contact: Bryan Cheplic
Public Release: 22-Jul-2013
Annals of Surgical OncologyPhysician bonuses help drive increases in surgery with minimal patient benefit: McMaster study Financial incentives for Ontario surgeons are likely a key factor driving greater use of laparoscopic colon cancer surgery as few benefits to patients, says McMaster University surgeon in paper published in Annals of Surgical Oncology.
Canadian Institutes for Health Research
Contact: Susan Emigh
Public Release: 22-Jul-2013
Sexually Transmitted InfectionsVaccinating boys plays key role in HPV prevention Improving vaccination rates against the human papillomavirus (HPV) in boys is key to protecting both men and women, says new research from University of Toronto Professor Peter A. Newman from the Factor-Inwentash Faculty of Social Work. HPV has been linked to anal, penile and certain types of throat cancers in men. Since the virus is also responsible for various cancers in women, vaccinating boys aged 11 to 21 will play a crucial role in reducing cancer rates across the sexes. Contact: Michael Kennedy
Public Release: 22-Jul-2013
BMC Complementary and Alternative MedicineIntegrative medicine interventions found to significantly reduce pain, improve quality of life An integrative approach to treating chronic pain reduces pain severity while improving mood and quality of life, according to a new study from the Bravewell Practice-Based Research Network published last month in BioMed Central Complementary and Alternative Medicine journal. Researchers found a reduction in pain severity of more than 20 percent and a drop in pain interference of nearly 30 percent in patients after 24 weeks of integrative care. Contact: Lauren Adams
Public Release: 21-Jul-2013
Nature ImmunologyA first in front line immunity research Monash University researchers have gained new insight into the early stages of our immune response, providing novel pathways to develop treatments for diseases from multiple sclerosis to cancer.
National Health and Medical Research Council, ARC
Contact: Emily Walker
Public Release: 19-Jul-2013
eLifeNew plan of attack in cancer fight New research by Harvard scientists shows that, under certain conditions, using two drugs in a "targeted therapy" -- a treatment approach designed to interrupt cancer's ability to grow and spread -- nearly all cancers could be effectively cured. Contact: Peter Reuell
Public Release: 19-Jul-2013
Psychological ScienceIf you're not looking for it, you probably won't see it In a new study from Brigham and Women's Hospital in Boston, researchers have found that even expert searchers, operating in their domain of expertise, are vulnerable to inattentional blindness. Contact: Jessica Maki
Public Release: 19-Jul-2013
Nature Cell BiologyStem cell discovery furthers research on cell-based therapy and cancer Stem-cell researchers at UC San Francisco have found a key role for a protein called BMI1 that may help scientists direct the development of tissues to replace damaged organs in the human body.
National Institutes of Health, California Institute for Regenerative Medicine
Contact: Jeffrey Norris
Public Release: 19-Jul-2013
Proceedings of the National Academy of SciencesStudy finds missing piece of pediatric cancer puzzle Most of the time, it takes decades of accumulating genetic errors for a tumor to develop. While this explains the general occurrence of cancer in adults, it leaves a gap in understanding of the cause of pediatric tumors. Contact: Gina Bericchia
Public Release: 18-Jul-2013
American Journal of Public HealthStudy finds boys more likely to receive HPV vaccine when their mothers receive preventive care Boys are more likely to receive the quadrivalent human papillomavirus vaccine if their mothers receive flu shots or Pap screenings, according to a Kaiser Permanente study published in the American Journal of Public Health.
Kaiser Permanente Southern California
Contact: Catherine Hylas Saunders
Public Release: 18-Jul-2013
American Journal of PathologyOvarian cancer metastases influenced by factors in target tissues Cancer researchers have wondered why ovarian cancer cells are so attracted to the abdominal cavity, especially the omentum, with the hope that such understanding could lead to better disease management or even prevention. Results from a series of experiments suggest a two-step model of omental colonization in the abdominal cavity in which i) cancer cells are attracted to and lodge within immune cell-containing structures known as milky spots, and ii) fat storage cells (adipocytes) fuel cancer cell growth and spread. Contact: Eileen Leahy
Public Release: 18-Jul-2013
Annals of OncologyModerate dose radiotherapy effective in EORTC trial for patients with desmoid-type fibromatosis A phase 2 EORTC trial for patients with inoperable desmoid-type fibromatosis has shown that moderate dose radiotherapy is an effective treatment for patients with such a rare type of tumor. The study results published in Annals of Oncology show that response after radiation therapy is slow, and that continuing regression is seen even after three years.
Fonds Cancer
Contact: John Bean
Public Release: 18-Jul-2013
ScienceThwarting protein production slows cancer cells' malignant march Protein production or translation is tightly coupled to a highly conserved stress response -- the heat shock response and its primary regulator, heat shock factor 1 (HSF1) -- that cancer cells rely on for survival and proliferation, according to Whitehead Institute researchers. In mouse models of cancer, therapeutic inhibition of translation interrupts HSF1's activity, dramatically slowing tumor growth and potentially rendering drug-resistant tumors responsive to other therapies.
National Institutes of Health, Johnson & Johnson Focused Funding Program, Marble Fund, American Cancer Society New England
Contact: Nicole Rura
Public Release: 18-Jul-2013
American Journal of Physical Medicine & RehabilitationCancer 'prehabilitation' can reduce complications and improve treatment outcomes For patients with cancer, "prehabilitation" -- interventions given between the time of diagnosis and the start of treatment -- has the potential to reduce complications from treatments and improve physical and mental health outcomes, according to a report in the August American Journal of Physical Medicine & Rehabilitation (AJPM&R). AJPM&R, the official journal of the Association of Academic Physiatrists, published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. Contact: Connie Hughes
Public Release: 18-Jul-2013
Proceedings of the National Academy of SciencesDeadliest cancers may respond to new drug treatment strategy UC San Francisco researchers have found a way to knock down cancers caused by a tumor-driving protein called "myc," paving the way for patients with myc-driven cancers to enroll in clinical trials for experimental treatments.
National Institutes of Health, Waxman Foundation, Howard Hughes Medical Institute, Truitt
Contact: Jeffrey Norris
Public Release: 18-Jul-2013
NatureRI Hospital: Absence of specific enzyme in cartilage can lead to benign tumors in mice Rhode Island Hospital researchers have found that the absence of the Shp-2 enzyme near specialized cartilage cells can lead to the development of multiple benign cartilage tumors in mice, a model that recapitulates the rare human tumor syndrome metachondromatosis. Shp2 is an enzyme in the cell that regulates the activity of other proteins and signaling pathways. Mice lacking Shp2 formed two types of tumors: enchondromas and osteochondromas, and also developed deformed joints.
National Institutes of Health, NIH/National Institute for General Medicine Sciences
Contact: Ellen Slingsby
Public Release: 17-Jul-2013
2013 ASCO MeetingTGen-TD2-Scottsdale Healthcare breast cancer pilot study shows value of proteomic mapping The Side-Out Foundation's breast cancer pilot study, led by the Translational Genomics Research Institute, Translational Drug Development and Scottsdale Healthcare, has shown that cancer patients do better when their treatment is guided by molecular profiling. Specifically, 52 percent of patients with advanced breast cancer received clinical benefit -- meaning their disease was controlled for a longer time -- when their cancer was treated based on addressing the abnormal proteins in their tumor.
Side-Out Foundation
Contact: Steve Yozwiak
Public Release: 17-Jul-2013
Menopause: The Journal of the North American Menopause SocietyMenopause symptoms worse in cancer survivors Cancer survivors were twice as likely to experience severe menopausal symptoms compared to women who have not had cancer, a new Australian study has found. Contact: Rebecca Scott
Public Release: 17-Jul-2013
Molecular PharmacologyCompounds outsmart solid tumors' malfunctioning machinery Molecular biologists in the School of Medicine at The University of Texas Health Science Center San Antonio have found a novel way to fine-tune the activity of cells' protein-disposing machinery, with potentially cancer-fighting effects.
Mike Hogg Foundation, William and Ella Owens Medical Research Foundation
Contact: Will Sansom
Showing releases 76-100 out of 1216. << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>
|
Search News Releases
|
|||||||||||||||||||||||||
 |
||||
|
|
 |
|